Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-11-25

FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application for Voltaren Arthritis Pain (diclofenac sodium) filed by Haleon US Holdings LLC. The approval updates the product labeli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Voltaren Arthritis Pain (Diclofenac sodium)

Snippet

SUPPL AP for VOLTAREN ARTHRITIS PAIN (DICLOFENAC SODIUM)